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The purpose of this study was to investigate what xylitol and sorbitol could 
affect on the enzymatic and candidacidal activities of lysozyme, the peroxidase 
system, and the glucose oxidase-mediated peroxidase system. 
Xylitol and sorbitol were added to hen egg-white lysozyme, bovine 
lactoperoxidase, glucose oxidase-mediated peroxidase, and whole saliva in 
solution and on the hydroxyapatite surface phases. The enzymatic activities of 
lysozyme, peroxidase, and glucose oxidase-mediated peroxidase were 
determined by measuring the turbidity of a Micrococcus lysodeikticus 
suspension, the rate of oxidation to 5,5’-dithiobis-2-nitrobenzoic acid by 
hypothiocyanite, and the production of oxidized o-dianisidine, respectively. 
Candidacidal activities were determined by comparing colony forming units 
 
and calculating the percent loss of cell viability using Candida albicans ATCC 
10231, 11006, and 18804. 
Both xylitol and sorbitol did not affect the enzymatic activity of hen egg-
white lysozyme both in solution and on the hydroxyapatite surface phases, 
while both sugar alcohols inhibited the enzymatic activity of salivary lysozyme 
significantly in solution phase, but not on the surface phase. Both xylitol and 
sorbitol enhanced the enzymatic activities of both bovine lactoperoxidase and 
salivary peroxidase significantly by dose-dependent manner in solution phase, 
but not on the surface phase. Sorbitol, not xylitol, inhibited the enzymatic 
activity of glucose oxidase-mediated peroxidase significantly. Both xylitol and 
sorbitol did not affect the candidacidal activities of hen egg-white lysozyme, 
the bovine lactoperoxidase system, and the glucose oxidase-mediated bovine 
lactoperoxidase system. 
Conclusively, xylitol and sorbitol inhibited salivary lysozyme activity, but 
enhanced both bovine lactoperoxidase and salivary peroxidase activities 
significantly in solution phase. Xylitol and sorbitol were not additive to the 
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Xylitol and sorbitol, the most widely used sugar alcohols, have common 
properties such as   the absence of reducing carbonyl group, the ability to 
complex with metal ions, and the ability to compete with water molecules.1) 
Sugar alcohols have been used as food ingredients for sweetener instead of 
sucrose, and could help prevent diabetes and obesity because of lowering blood 
glucose level.2) Especially xylitol among sugar alcohols, has been included in 
many oral health care products because xylitol was proved to be beneficial for the 
prevention of dental caries by inhibiting glycolytic pathway for bacterial growth 
and acid production.3,4) Xylitol and sorbitol have also been known for alleviating 
dry mouth by stimulation of salivary secretion like other sweeteners.5) 
The increase of geriatric population which accompanies the increase of 
population under medications and chronic illnesses, leads to higher prevalence of 
individuals with dry mouth.6) Individuals who suffer from dry mouth usually 
experience a variety of signs and symptoms such as ulcerations and pain in oral 
mucosa, difficulty in chewing and swallowing, rampant dental caries, and 
recurrent oral candidal infections, which results in deteriorating the quality of 
life.7) These patients have been recommended to use artificial saliva or mouth 
rinse containing antimicrobials for the recovery of reduced salivary flow and 
impaired antimicrobial activities.8) 
The most widely used antimicrobial host proteins are lysozyme and peroxidase 
mainly originated from animals. Lysozyme distributed in a wide range of 
biological fluids such as saliva, tears, and respiratory secretions,9) provides 
antimicrobial activity through muramidase-, cation-, and structure-dependent 
mechanisms.10,11) Peroxidase is also ubiquitous and involved in antimicrobial 
activity and preventing oral tissue damage from oxygen toxicity by consuming 
hydrogen peroxide and producing hypothiocyanite.12) Peroxidase can be activated 
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with the peroxidase system rather than enzyme alone, and a commercially 
available form is the glucose oxidase-mediated peroxidase (GO-PO) system.13) 
Because these antimicrobial molecules are in the same environment, there must 
be evidently interactions between all components in oral health care products, and 
between these components and components in human saliva when applied to the 
oral cavity.14) These molecular interactions could occur not only in solution like 
saliva, but also on surface like tooth in the oral cavity. Immobilized proteins on 
the surface could cause conformational changes of them, which results in the 
alteration of their enzymatic activities.15-17) Therefore, the interactions on surface 
behave in a distinct way from those in solution. Interactions between 
antimicrobial proteins such as peroxidase and sIgA,18) peroxidase and 
lactoferrin,19,20) lysozyme and lactoferrin,21) lysozyme and histatins,22) lysozyme 
and the peroxidase system,23,24) and lysozyme and the GO-PO system,25) have 
been reported. There have also been reports on interaction between antimicrobial 
supplements and candidate substances of artificial saliva such as animal 
mucins,26,27) hyaluronic acid,25,28,29) and yam tuber mucilage.30,31) The results of 
interactions could be additive, synergistic, or inhibitory and the results of surface 
studies were not the same as those of solution ones. Sugar alcohols and 
antimicrobials could also be present in the same environment such as oral health 
care products and the oral cavity, therefore there might be interactions between 
them. The consumption of a xylitol diet has been reported to increase salivary 
peroxidase activity.32) However, there has been no report what sugar alcohols 
affect the enzymatic activities of important antimicrobials in solution and on the 
hydroxyapatite (HA) surface. There is also no report the effects of sugar alcohols 
on the candidacidal activities of antimicrobials commonly incorporated in 
artificial saliva products. The purpose of this study was to investigate the effects 
of xylitol and sorbitol on the enzymatic and candidacidal activities of lysozyme, 
the peroxidase system, and the GO-PO system. 
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II. REVIEW OF LITERATURE 
 
1. Sugar alcohols 
 
(1) Chemical profiles 
Sugar alcohols are white and sweet crystalline substances derived from 
aldose sugar. The general formula of them can be expressed as 
HOCH2(CHOH)nCH2OH. Sugar alcohols are divided into different types 
according to the length of chain and further differentiated by the spatial 
orientation of hydroxyl groups.33) The simple sugar alcohols have following 
common polyol properties.34) Sugar alcohols do not have reducing carbonyl 
group, which makes them chemically less reactive than corresponding aldoses 
and ketoses. Thus, sugar alcohols can avoid acidogenic and cariogenic 
development in dental plaque by dietary hexose-based sugars. Sugar alcohols 
can change coenzymes into chemically reduced products because they have 
remnant hydrogen atoms. A large amount of hydroxyl groups makes most sugar 
alcohols readily soluble in saliva and can support the native conformation of 
salivary proteins. Sugar alcohols can form complex formation with polyvalent 
cation like Ca2+ via polyoxy structure, which facilitates remineralization of 
caries lesions.35,36) Sugar alcohols are also potential source of free radical 
scavengers in many biological systems. However, sugar alcohols have 
differences in molecular masses and exert specific selective effects on 




Ethylen glycol and methanol, the simplest sugar alcohol, are toxic and used 
as antifreeze, but most of the other sugar alcohols are nontoxic and used as food 
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additives. Sugar alcohols are not so sweet as sucrose and have less calories than 
sucrose. Especially xylitol and sorbitol are well known not to be involved in 
dental caries because they are not metabolized by oral microbes.37) Most sugar 
alcohols are not absorbed completely in small intestines, which leads to lower 
blood glucose level compared with sucrose and be favorable to diabetic patients 
and low-caloric diet people.38) Some sugar alcohols often cause gastrointestinal 
distress like diarrhea and flatulence when overconsumed. Sorbitol can be used 
as non-stimulant laxatives because of drawing water in to large intestine.39) 
Some of sugar alcohols such as erythritol, xylitol, sorbitol and mannitol, extract 
chilling sense in oral cavity because endothermic reaction is required to 
dissolve them in saliva.40) 
 
(3) Xylitol 
Xylitol is pentitol and all five carbon atoms of the molecule bind an hydroxyl 
group. This tridentate ligand (H-C-OH)3 reacts with various polyvalent cations 
and oxyacids in reversible reactions. Xylitol is roughly as sweet as sucrose. One 
gram of ingested xylitol provides about two calories in human diets, while three 
calories in sucrose. Thus, xylitol has been widely used as sweetener in the diets 
of diabetic and hyperglycemic patients. Clinical research of xylitol called Truku 
sugar studies, were designed to be 2-year heavy loading with xylitol, fructose 
and sucrose, and 1-year trial with xylitol- or sucrose-sweetened chewing gum in 
Finland. These studies showed that the replacement of sugar by xylitol reduced 
caries progression.42,43) Several other trials are followed such as Yliviesk 
studies in Finland, Belize studies in central America, mother-child studies in 
Finland, Sweden and Japan.44-47) These long-term clinical trials and consensus 
all over the world suggest that there are sufficient evidences that positive dental 
benefits result from the use of xylitol as food component. Similar results were 
obtained from the examples of animal experiments.48-50) The safety of xylitol 
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had been thoroughly studied in humans and the long-term use of xylitol was 
proved not to be harmful.51) Studies in Hungary and French Polynesia showed 
that substitution of xylitol for sugar resulted in more effective prevention of 
dental caries than fluoride use only.52,53) The recent mother-child studies 
showed that maternal use of xylitol gum prevented caries in infants more 
effectively than the topical use of fluoride.46) Some studies reported that 
substitution of xylitol for sugar led to remineralization of caries lesions. Other 
studies suggested that xylitol could exert specific effects on dental caries not 
shown by hexitols. However, all xylitol studies did not reach positive clinical 
and biologic findings. A recommended practice is to use 6-7 g of xylitol daily, 
preferably in 3–5 separate chewing and sucking episodes after main meals.34) 
Not only chewing gum but also other xylitol-containing products such as tablets, 




Sorbitol is a hexitol-type bulk sweetener and its molecular structure is similar 
to that of D -glucose. Sorbitol is crystalline substance with lower sweet taste 
and calories compared with sucrose. Sorbitol also shares the common polyol 
properties, but it is different from xylitol in molecular mass and ligands. Some 
clinical caries trials were carried out on sorbitol. Five-minutes chewing has 
been found to provide more meaningful results because prolonged salivation 
may mask desired pharmacologic sugar alcohol effects. Sorbitol has 
significantly reduced the incidence of caries when compared with sucrose. 
However, the efficacy seems to be weaker, when compared with xylitol.54) The 
reason may be explained by microbiologic and molecular parameters of sorbitol 
which normally stimulates the growth of some strains of Streptococcus mutans, 
retards the growth of dental plaque, and is readily convertible to glucose and 
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fructose serving as substrates for cariogenic, plaque-building organisms in 
dental plaque. Mixtures of xylitol and sorbitol do exert positive dental effects, 
more significant decrease of plaque mass and more distinct lowering of oral 
counts of cariogenic bacteria have been observed.55)  
 
2. Salivary antimicrobials 
 
(1) Developments of salivary antimicrobial molecules 
Saliva is indispensable for good oral health, because it not only maintains 
oral functions but it also protects oral tissues from noxious agents derived from 
microorganisms, food and environmental stress. Saliva protects oral tissues in 
several ways. Saliva contains many innate or acquired defense systems. During 
early childhood innate salivary factors work already at almost full capacity. 
Lysozyme, salivary peroxidase, and hypothiocyanite are already at levels 
similar to those of adults, while lactoferrin, myeloperoxidase, and total protein 
are still insufficient in the saliva of infants.56) All non-immune factors reach 
adult levels by the early teens.57) These factors remain at high concentrations 
even among elderly people.58) Salivary antibodies against oral pathogens are 
induced by the gut- or duct-associated lymphoid tissues, which produces 
protective antibodies on mucosal surfaces.59) Salivary sIgA antibodies to 
mucosal bacteria begin to appear as early as the first weeks of life, and they 
approach adult levels by 1 to 2 year old.60) There are also serum-derived 
antibodies such as IgG isotype in whole saliva. These IgG antibodies to oral 
microbes have been detected in 1 year old61,62) and enter into whole saliva 
through the gingival crevice.63) Particularly, saliva has been reported to increase 
serum IgG retention on S. mutans cells among caries-resistant people,64) which 
means that serum-derived IgG antibodies to oral pathogens could also have a 





Salivary lysozyme is derived from major salivary glands, minor salivary 
glands, phagocytic cells, and gingival crevicular fluid. The epithelial cells 
lining the intralobular and intercalated ducts secrete and synthesize lysozyme in 
major salivary glands, while lysozyme is detected at the intralobular and 
intercalated ducts as well as in serous acinar cells in minor salivary glands. 
Lysozyme mainly kills gram-positive bacteria with surface-exposed 
peptidoglycan, because lysozyme can hydrolyze β-1,4-glycosidic bonds 
between N-acetylmuramic acid and N-acetyl-D-glucosamine of bacterial cell 
wall peptidoglycan.10) Digestion of peptidoglycan structures via salivary 
lysozyme may also assist antimicrobial cationic peptides of saliva to get across 
peptidoglycan layers of bacterial membranes. Lysozyme plays an important 
role in membrane-permeable property, which leads to non-enzymatic 
antimicrobial activity against both gram-positive and gram-negative bacteria as 
well as fungi.65,66) Lysozyme can bind to bacterial lipopolysaccharide 
responsible for tissue destructive inflammatory reactions.67) Besides the above, 




There are two types of peroxidase system in saliva, namely lactoperoxidase 
and myeloperoxidase. Lactoperoxidase is produced by salivary glands, while 
myeloperoxidase is produced by neutrophil granulocytes entering the oral 
cavity and also derived from gingival crevicular fluid. Salivary peroxidase 
catalyze the oxidation of thiocyanate (SCN-) by hydrogen peroxide, which 
leads to the production of much more bactericidal and fungicidal 
hypothiocyanite (OSCN-).70) Duox-1 is localized in the luminal plasma 
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membrane of epithelial cells of terminal collecting ducts of major salivary 
glands, and provides hydrogen peroxide for salivary peroxidase just prior to 
delivery into the oral cavity.71) 
 
(4) Glucose oxidase-mediated peroxidase 
The actual supplements for the peroxidase system in oral health care 
products are GO-PO system which consists of bovine lactoperoxidase (bLPO), 
glucose oxidase, and SCN-. Glucose oxidase convert glucose into oxidative 
glucono-lactone and generates hydrogen peroxide which serves as a substrate 
for bLPO and peroxidase in saliva during formation of antimicrobial OSCN- 
from of SCN-.13) Glucose oxidase could hamper the carbohydrate metabolism 
of glycolytic cariogenic bacteria by the depleting glucose. 
 
(5) Clinical and commercial use 
Lysozyme and lactoferrin purified from bovine colostrum can be added into 
oral health care products, such as toothpastes and mouth-rinses. Biotene® , 
Oralbalance® , BioXtra®  and Zendium Saliva®  are commercial products used 
currently. These products can contain growth factors, such as IGF-1, TGF-β1 
and TGF- β2.72) However, it is not remarkable if these have any effects on 
mucosal tissues. Human lactoferrin, or its antimicrobial 25-residue peptide 
fragment lactoferricin B, has recently been cloned by fermentation of 
Aspergillus niger. Recombinant human lactoferrin will be more preferable than 
bovine milk derived lactoferrin for future, because it has been reported to be 
active and safe for human clinical use. It is difficult to purify human salivary 
peroxidase in large scale because of unfavorable cost effect. Thus, bLPO 
purified from milk or colostrum has been used commercially, because it is 
structurally and catalytically close to human salivary peroxidase. Hydrogen 
peroxide can be produced in situ in the mouth, when oral hygiene products with 
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glucose and glucose oxidase system are used. Biotene® , BioXtra® , Zendium 
Saliva®  and Oralbalance®  are commercial products incorporating 
lactoperoxidase system. These products comprise toothpaste, non-alcoholic 
mouth-rinse, xylitol-flavored chewing gum, moisturizing gels and denture 
adhesives for patients with dry mouth problems. All commercialized products 
containing lactoperoxidase system are non-foaming because detergents 
inactivate the enzymes.  
 
3. Molecular interactions 
 
There is no clear evidence that any one of antimicrobial agents in saliva is 
more important than the others. Meanwhile, it is more important that many 
salivary antimicrobial agents interact each other simultaneously in solution and 
on surface phase, that their concentrations tend to be correlated, and that they 
depend on pathophysiological condition age, salivary flow rate, acidic pH and 
so on. Many of their interactions are synergistic or additive way in most cases. 
For example, such interactions between sIgA and peroxidase,18) lactoferrin and 
peroxidase,19,20) lactoferrin and lysozyme,21) and lysozyme and histatins22) were 
reported. Although these observations are from in vitro experiments, it seems 
that these concerted effects extend into in vivo systems, where all the 
components are simultaneously present. Therefore, salivary antimicrobial 
agents form a network where single component may be insufficient for the 
overall antimicrobial capacity of the host's defense system. Lysozyme and 
lactoferrin have been incorporated in some of these products to further mimic 
the in vivo situation, and that fluoride ions in these products have an additive 
effect with OSCN- against S. mutans.76) Specific antibodies of S. mutans in 
bovine immune whey inhibit extracellular polysaccharide formation by S. 
mutans, aggregate both S. mutans and Streptococcus sobrinus cells, prevent the 
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adherence of S. mutans to saliva-coated hydroxyapatite, and support the 
phagocytosis and killing of S. mutans by human leukocytes.77) In addition, 




(1) Prevalence  
The prevalence of xerostomia in general population ranges from 0.9% to 
64.8%, depending on population-based samples.79) However, patients with 
Sjögren’s syndrome and those who are receiving radiation therapy for head and 
neck cancer almost suffer from xerostomia without exception.80) The 
prevalence increases with age, thus about 30% of the population older than 65 
experience dry mouth.80) Xerostomia is more prevalent in postmenopausal 
women compared to men. Especially, those who had taken antidepressants 
showed 22 times higher risk for xerostomia. 
 
(2) Etiology 
The most common medications causing hyposalivation are anticholinergics, 
sympatomimetics and benzodiazepines ant they are the most commonly 
prescribed medications in geriatric population.81) Salivary gland hypofunction 
and chronic xerostomia can also be derived from the side effect of autoimmune 
disorders such as Sjögren’s syndrome,82) rheumatoid disorders, scleroderma and 
lupus;83) endocrine disorders such as uncontrolled diabetes, adrenal gland 
diseases84) and graft versus host disease (GVHD);85) advanced stages of human 
immunodeficiency virus (HIV) infection,86) chronic or neurogenic pain, 
malnutrition, smoking,87) alcohol or caffeine-containing fluids, mouth breathing 
and iatrogenic procedures and regimens.88-90) The subjective symptom of dry 
mouth can also result from the change in cognitive abilities of the central 
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nervous system following a stroke.91) Xerostomia and salivary gland 
hypofunction are major complications of head and neck radiation therapy and 
chemotherapy. Irradiation and cytostatic drugs result in sialoadenitis following 
irreversible damage of acinar cells of salivary glands.88) 
 
(3) Clinical signs and symptoms 
Dry mouth is a subjective feeling. Xerostomia is not equal to hyposalivation 
because it may occur with the changes in the quality and without the changes of 
the amount of saliva. Dry mouth is one of the most common and unpleasant 
symptom which adversely affects all oral functions and compromise oral health. 
Patients with xerostomia usually experience difficulties while speaking, 
chewing, swallowing and wearing dentures.80,88-91) Oral mucosa is prone to 
injuries, fungal infection and inflammation and readily experience painful 
burning sensations.92) Taste is also altered and even halitosis is present. The 
parotid glands become visibly enlarged in those with Sjögren’s syndrome. 
Hyposalivation increases the risk of developing caries, enamel erosions and 
periodontal diseases.88,89) The lack of lubrication can cause traumatic 
ulcerations of the mucosa and increased susceptibility to candidiasis in patient 
with dentures. 
 
 (4) Treatment 
Treatment modalities are divided into etiologic, stimulative, symptomatic or 
palliative approach depending on the cause and the severity of diseases. The 
combination of chewing gums or solid food or acidic fruits can be effective in 
stimulating salivary flow for patients with intact salivary function. Acupuncture 
have focused mainly on a curative approach when the salivary gland tissues are 
already damaged.93) However, it is considered to be efficient as preventive 
approach in the management of patients with head and neck cancer undergoing 
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radiotherapy recently. Only four sialagogues such as bromhexine, 
anetholetrithione, pilocarpine hydrochloride (HCl), and cevimeline HCl among 
systemic stimulants, have been studied extensively, but results were 
controversial.94) Bromhexine has not proven to be beneficial to salivary 
function, yet it may stimulate lacrimal function in patients with Sjögren’s 
syndrome. Anetholetrithione has been suggested to up-regulate muscarinic 
receptors and increased saliva flow in patients with mild salivary gland 
hypofunction. Pilocarpine HCl is a parasympathomimetic agent and causes 
stimulation of cholinergic receptors on the surface of acinar cells. Cevimeline is 
another parasympathomimetic agonist. A number of saliva substitutes have 
been developed for the palliative care of patients with salivary hypofunction. 
These agents, in liquid, spray, or gel form have moistening and lubricating 
properties, and are aimed to provide prolonged wetness of the oral mucosa. 
 
5. Development of artificial saliva  
 
(1) Current issues 
There is no choice except palliative treatment, if the salivary secretory cells 
is damaged irreversibly and impaired completely. The best remedies available 
today are only symptomatic and alleviate discomfort and pain resulting from 
xerostomia like artificial saliva. Patients with irreversible xerostomia should be 
instructed to maintain adequate hydration of the oral cavity by taking plenty of 
fluids throughout the day and using artificial saliva preparations. 
 
(2) Clinical and commercial use 
There has been attempts to replace normal saliva with a variety of different 
solutions. The simplest form is water, but it is too short lived. Thus, Carboxy-
methy-cellulose (CMC) is added for obtaining proper viscosity, and it makes 
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salivary substitute last for a longer period than water alone.95) Buffered 
solutions include calcium, phosphate and fluoride ion for improving the 
qualities of artificial saliva. Polyethylene oxide is added for modifying 
rheological properties. Mucin containing solution often dilute with artificial 
saliva. Commercially available products are divided into five classes;96) 
aqueous-ion solution as liquid form; aqueous-ion CMC solution as spray, 
aerosol and liquid form; mucin-containing preparation as spray, lozenge and 
gum type; glycoprotein-containing solution as liquid form; enzyme-containing 
solution as gel type. CMC and mucin-containing saliva substitute are lower 
contact angle and better wetting property than water.97) The rheological 
property affects the coating and lubrication of oral surface and the consistency 
of ingested food. Dry mouth reduces influx of fluid. Therefore, it is necessary 
to add adequate rheological properties to artificial saliva. Facilitating 
lubrication and reducing sensation of dry mouth improve chewing, swallowing 
and speech.98) The addition of calcium, phosphate and fluoride ions into 
artificial saliva is beneficial for the prevention of dental caries and the 
remineralization of enamel. 
   
(3) Future aspects  
It is necessary to consider the design and composition of salivary substitutes 
that disease-oriented as well as function-oriented. Customized artificial saliva 
can be applied with site-specific monoclonal antibodies against individual 
levels of molecules in saliva and tooth pellicles, because adequate amounts of 
molecules could be included in this replacement therapy. The advanced 
techniques in computer modelling to design relevant functional domain and use 
of peptide engineering to synthesize this domain, permit the development of 
composite salivary molecules with greater substantivity, biocompatibility and 
selectivity for precise localization. 
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III. MATERIALS AND METHODS 
 
1. Collection of human saliva 
 
Saliva samples were collected from 4 healthy adult participants (2 men and 2 
women) between 8 am and 12 pm to minimize variability in salivary composition. 
The participants kept from eating, drinking, and tooth brushing for at least 1 h 
before saliva collection. Unstimulated whole saliva was collected by the spitting 
method.99) Saliva was placed in a chilled centrifuge tube in which 
phenylmethylsulphonylfluoride (PMSF) was added immediately to final 
concentrations of 1.0 mM. The saliva sample was centrifuged at 3,500xg for 15 
min at 4C, and the resulting clarified supernatant fluid was used immediately for 
assays. The research protocol was approved by the Institutional Review Board of 
the Seoul National University Dental Hospital (#CRI13005). 
 
2. Lysozyme, peroxidase, the peroxidase system, the GO-PO system, and 
sugar alcohols 
 
Reagents were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, 
USA) unless stated otherwise. 
Hen egg-white lysozyme (HEWL, final concentration of 30 g/mL) and bLPO 
(final concentration of 25 g/mL) served as the sources of lysozyme and 
peroxidase, respectively, in all experiments. For candidacidal assays, the 
peroxidase system included final concentrations of 25 g/mL bLPO, 1 mM 
potassium thiocyanate (KSCN), and 50 M hydrogen peroxide (H2O2). The GO-
PO system included final concentrations of 25 g/mL bLPO, 1 mM KSCN, 50 
g/mL GO from A. niger, and 0.03 mg/mL glucose. Among sugar alcohols, 
xylitol and sorbitol were used. All components were dissolved in simulated 
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salivary buffer (SSB, 0.021 M Na2HPO4/NaH2PO4, pH 7.0, containing 36 mM 
NaCl and 0.96 mM CaCl2.
100) 
 
3. Measurement of enzymatic activities of lysozyme, peroxidase, and GO-PO 
 
Lysozyme activity was determined by the turbidimetric method,101) in which 
the degradation rate of lyophilized cell suspension of Micrococcus lysodeikticus 
ATCC 4698 was measured. Peroxidase activity was determined by the NbsSCN 
assay which measures the rate of oxidation of 5-thio-2-nitrobenzoic acid (Nbs) to 
5,5-dithiobis(2-nitrobenzoic acid) (Nbs)2. 
102) The enzymatic activity of GO-PO 
was measured using a glucose assay kit, which measures oxidized o-dianisidine 
production. 
 
4. Influences of xylitol and sorbitol on the enzymatic activity of lysozyme in 
the solution phase 
 
The effects of xylitol and sorbitol on the enzymatic activity of HEWL and 
whole salivary lysozyme in the solution phase were examined by incubating 500 
μL of xylitol or sorbitol at different concentrations (final concentrations of 32.5, 
65, 130, and 260 mM) with 500 μL of HEWL (final concentration of 30 μg/mL) 
or clarified whole saliva for 10 min at room temperature (RT). Incubated mixture 
was placed in a suspension of M. lysodeikticus, and incubated buffer with HEWL 
or clarified whole saliva was a control. An incubated mixture of xylitol or 
sorbitol with the buffer or an incubated buffer alone was used as a blank. The 
experiment was duplicated and performed 6 times for HEWL. For whole saliva, 
saliva samples were collected twice in different days from 4 participants. The 




5. Influences of xylitol and sorbitol on the enzymatic activity of lysozyme on 
the HA surface phase 
 
To determine the influences of xylitol and sorbitol on the enzymatic activity of 
lysozyme adsorbed to a HA surface, experiments were performed in 2 ways; In 
assay I, the effects of adsorbed xylitol or sorbitol on subsequent adsorption of 
lysozyme were examined. In assay II, HA-adsorbed lysozyme activity was 
examined after pre-incubation of xylitol or sorbitol with lysozyme. Ceramic HA 
beads (Macro-prep, HA type I) were obtained from Bio-Rad (Hercules, CA, USA) 
and used a solid phase. Ten milligrams of HA beads were used in each assay. 
In assay I, HA beads were coated with 300 μL of xylitol or sorbitol (final 
concentrations of 130 and 260 mM) for 30 min at RT. After coating, the beads 
were washed 5 times with the buffer. The xylitol- or sorbitol-coated HA beads 
were then incubated with 300 μL of HEWL or clarified whole saliva samples for 
30 min at RT. Unbound HEWL or salivary molecules were removed by 5 washes. 
The beads were incubated with a suspension of M. lysodeikticus, and lysozyme 
activity was determined as described above. The lysozyme activities of these 
samples were compared with those of the bare HA surfaces coated with HEWL or 
clarified whole saliva. 
In assay II, 300 L of xylitol or sorbitol (final concentrations of 130 and 
260mM) was incubated with 300 L of HEWL solution or clarified whole saliva 
samples for 10 min at RT. HA beads were incubated with 600 L of the mixture 
for 30 min at RT, then washed 5 times with the buffer to remove unbound 
molecules. Lysozyme activities of these samples were compared with those of the 
HA samples coated with the pre-incubated mixture of HEWL or clarified whole 
saliva with buffer. 
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All the experiments was duplicated and performed 6 times for HEWL and 8 
times for whole saliva. Equal amounts of HA beads incubated with xylitol or 
sorbitol, or an incubated buffer alone were used as blanks. 
 
6. Influences of xylitol and sorbitol on the enzymatic activity of peroxidase in 
the solution phase 
 
The effects of xylitol and sorbitol on the enzymatic activity of bLPO or whole 
salivary peroxidase in the solution phase were examined by incubating 500 μL of 
xylitol or sorbitol (final concentrations of 32.5, 65, 130, and 260 mM) with 500 
μL of bLPO (final concentration of 25 μg/mL) or clarified whole saliva for 10 
min at RT. The influences of different mixtures of xylitol and sorbitol (3:1, 2:2, 
and 1:3 in molar concentrations) on the enzymatic activity of bLPO were also 
examined. For NbsSCN assay, 15 L of KSCN (final concentration of 4.2 mM 
SCN-) and 15 L of sample solution were added to 300 L of reaction mixture, 
and reaction was initiated by the addition of 15 L of H2O2 (final concentrations 
were 25 M for bLPO and 100 M for whole saliva). An incubated mixture of 
buffer with either bLPO or clarified whole saliva was used as a control. For the 
blank reaction, an incubated mixture of xylitol or sorbitol with buffer, or an 
incubated buffer alone was used. All the experiments was duplicated and 
performed 6 times for HEWL and 8 times for whole saliva. 
 
7. Influences of xylitol and sorbitol on the enzymatic activity of peroxidase 
on the HA surface phase 
 
Like the lysozyme assays, experiments were also performed in 2 ways; In 
assay I, the effects of adsorbed xylitol or sorbitol on subsequent adsorption of 
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peroxidase were examined. In assay II, HA-adsorbed peroxidase activity was 
examined after pre-incubation of xylitol or sorbitol with peroxidase. 
In assay I, HA beads were coated with 300 μL of xylitol or sorbitol (final 
concentrations of 130 and 260 mM) for 30 min at RT. After coating, the beads 
were washed 5 times with the buffer. The xylitol- or sorbitol-coated HA beads 
were then incubated with 300 μL of bLPO or clarified whole saliva samples for 
30 min at RT. Unbound bLPO or salivary molecules were removed by 5 washes. 
The beads were used for the NbsSCN assay. The peroxidase activities of these 
samples were compared with those of the bare HA surfaces coated with bLPO or 
clarified whole saliva. 
In assay II, 300 L of xylitol or sorbitol (final concentrations of 130 and 260 
mM) was incubated with 300 L of bLPO solution or clarified whole saliva 
samples for 10 min at RT. HA beads were incubated with 600 L of the mixture 
for 30 min at RT, then washed 5 times with the buffer to remove unbound 
molecules. Peroxidase activities of these samples were compared with those of 
the HA samples coated with the pre-incubated mixture of bLPO or clarified whole 
saliva with buffer. 
All the experiments was duplicated and performed 6 times for bLPO and 8 
times for whole saliva. Equal amounts of HA beads incubated with xylitol or 
sorbitol, or an incubated buffer alone were used as blanks. 
 
8. Influences of xylitol and sorbitol on the enzymatic activities of GO-PO 
 
The GO-PO reagent in the glucose assay kit was divided into two parts, one 
dissolved in SSB and the other dissolved in SSB containing xylitol or sorbitol 
(final concentration of 130 mM), and pre-incubated for 30 min at RT. Enzymatic 
activity of the two different GO-PO reagents was measured using samples with 
known glucose concentrations (0.02, 0.04, and 0.06 mg/mL). Oxidized o-
19 
 
dianisidine production, measured by the ODs at 540 nm, reflected the enzymatic 
activity of GO-PO reagents. The influences of different mixtures of xylitol and 
sorbitol (3:1, 2:2, and 1:3 in molar concentrations) on the enzymatic activities of 
GO-PO were also examined. Experiments were duplicated and performed 8 times. 
 
9. Influences of xylitol and sorbitol on the candidacidal activities of lysozyme, 
the peroxidase system and the GO-PO system 
 
One colony of Candida albicans (ATCC 18804, 10231, and 11006) grown on 
Sabouraud dextrose agar (SDA) was inoculated into 10 mL Sabouraud dextrose 
broth and incubated with shaking at 37℃ for 18 h. Cells were harvested, washed, 
and resuspended to 1 ⅹ 105 cells per mL in SSB. Twenty microliters of xylitol 
or sorbitol (final concentration of 130 mM) solution was added to 20 L of 
HEWL, or the peroxidase system, or the GO-PO system and incubated with 
shaking at 37℃ for 30 min. The mixture was added to 20 L of the cell 
suspension and incubated with shaking at 37℃ for 1 h. After the incubation, the 
sample was diluted 10-fold, and 50 L of the diluted cells was plated onto SDA 
plates in triplicate and grown overnight at 37℃. Candidacidal activity was 
determined by comparing the number of colonies (colony forming units, CFUs) 
between plates containing mixtures of sugar alcohols and antimicrobials and ones 
containing only antimicrobials. The percent loss of cell viability was calculated as 
1 minus the ratio of the number of colonies on the test and control (no sugar 









The Wilcoxon signed rank test and Mann-Whitney U-test were used to analyze 
statistical differences between two variables. The Kruskal-Wallis test was also 
used to analyze statistical differences and the Mann-Whitney U-test with 
Bonferroni’s correction was used as post-hoc analysis. For each test, a P-value 








1. Influences of xylitol and sorbitol on the enzymatic activity of lysozyme in 
the solution phase 
 
Both xylitol and sorbitol did not affect the enzymatic activities of HEWL, but 
significantly inhibited the enzymatic activities of salivary lysozyme (P < 0.05) in 
the solution phase. At 2 time-increase of xylitol and sorbitol concentrations (final 
concentrations of 260 mM), the enzymatic activities of HEWL were not affected 
either (data not shown). The effects of xylitol and sorbitol on the enzyme 
activities of salivary lysozyme were concentration-dependent significantly (P < 
0.05). The effect of sorbitol on the enzymatic activities of salivary lysozyme was 





2. Influences of xylitol and sorbitol on the enzymatic activity of lysozyme on 
the HA surface phase 
 
Both xylitol and sorbitol did not affect the adsorption and subsequent 
enzymatic activity of HEWL and salivary lysozyme on the HA surfaces when 
xylitol or sorbitol was adsorbed first or was pre-incubated with HEWL or whole 
saliva (Table 2). At 2 time-increase of xylitol and sorbitol concentrations (final 
concentrations of 260 mM), the results were the same (data not shown). 
 
3. Influences of xylitol and sorbitol on the enzymatic activity of peroxidase in 
the solution phase 
 
Both xylitol and sorbitol enhanced the enzymatic activity of bLPO and salivary 
peroxidase significantly (P < 0.05) in the solution phase and the effects were 
greater in salivary peroxidase. The effects of xylitol and sorbitol on the enzyme 
activities of bLPO and salivary peroxidase were concentration-dependent 
significantly (P < 0.05). There were no significant differences between the effects 
of xylitol and sorbitol at the same concentration on the enzyme activities of bLPO 
and salivary peroxidase (Table 3). 
As expected, the mixtures of xylitol and sorbitol with different ratios also 
enhanced the enzymatic activities of bLPO significantly (P < 0.05). However, the 
relative ratios of the mixtures did not affect the effects on the enzyme activities of 
bLPO significantly (Table 4). 
 
4. Influences of xylitol and sorbitol on the enzymatic activity of peroxidase 
on the HA surface phase 
 
Both xylitol and sorbitol did not affect the adsorption and subsequent 
enzymatic activity of bLPO and salivary peroxidase on the HA surfaces when 
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xylitol or sorbitol was adsorbed first or was pre-incubated with bLPO or whole 
saliva (Table 5). At 2 time-increase of xylitol and sorbitol concentrations (final 
concentrations of 260 mM), the results were the same (data not shown). 
 
5. Influences of xylitol and sorbitol on the enzymatic activity of GO-PO 
 
Xylitol did not affect the enzymatic activity of GO-PO, while the enzymatic 
activity was inhibited by increasing the relative amounts of sorbitol. Sorbitol at 
130 mM and a 1:3 mixture of xylitol and sorbitol (at 32.5 mM xylitol and 97.5 
mM sorbitol) inhibited the enzymatic activity of GO-PO significantly (P < 0.05) 
and the effects increased as the glucose level increased (Table 6). 
 
6. Influences of xylitol and sorbitol on the candidacidal activities of lysozyme, 
the peroxidase system, and the GO-PO system 
 
The antimicrobial enzymes showed significant candidacidal activities in the 
order of the GO-PO system (%killing, 18.0 - 40.1%), the peroxidase system (18.6 
- 33.8%), and lysozyme (13.9 - 27.8%). All the three antimicrobials showed the 
highest candidacidal activities in ATCC 11006 and the lowest activities in ATCC 
10231. The pre-incubated mixtures of xylitol or sorbitol with lysozyme, the 
peroxidase system, or the GO-PO system did not show any additive candidacidal 











A large number of previous studies showed concerted interactions between 
antimicrobial host proteins and potential base molecules in artificial saliva as well 
as just between antimicrobial host proteins, both in solution and on surface phases. 
The peroxidase system enhanced the enzymatic and canididacidal activity of 
lysozyme.24) Hyaluronic acid which might be included in artificial saliva as a base 
molecule had inhibitory effects on the candidacidal activities of lysozyme, the 
peroxidase system, and the GO-PO system.25,29) The presence of animal mucins in 
artificial saliva affected the enzymatic activity of lysozyme on HA surfaces as 
well as in solution.26) Yam tuber mucilage enhanced the enzymatic activity of 
lysozyme on HA surfaces like animal mucin.30,31) 
Sugar alcohols have been used frequently in artificial saliva and oral health 
care products for their anticariogenic properties, but there has been no research 
about the influences of sugar alcohols on the enzymatic and candidacidal effects 
of antimicrobials. For this reason, we tried to investigate the effects of xylitol and 
sorbitol, the most popular sugar alcohols, on the enzymatic and candidacidal 
activities related with lysozyme and peroxidase in the present study. 
All sugar alcohols have common polyol properties such as absence of reducing 
carbonyl group, complex formation with polyvalent metal cations, and 
competition with water molecules.1) On the other hand, xylitol consists of five 
carbon atoms with hydroxyl group and sorbitol six carbon atoms, so that xylitol is 
differentiated from sorbitol in many biological reactions because of shorter 
structure.103) Phosphorylated xylitol which is xylitol-5-phosphate can easily 
participate in glycolytic pathway of S. mutans owing to less steric hindrance, and 
suppress bacterial growth and acid production.4) Different chemical structure of 
xylitol from sorbitol could not only contribute to decrease dental caries and 
adhesive potential of dental plaque more efficiently, but also provide systemic 
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merits such as appropriate regulation of blood glucose level with insulin 
elevation,2) retardation of osteoporosis,104) and prevention of otitis media.105) 
Both xylitol and sorbitol inhibited the enzymatic activities of salivary lysozyme, 
while they enhanced the enzymatic activities of bLPO and salivary peroxidase in 
this study. Lysozyme is known to hydrolyze polysaccharides of bacterial cell wall 
and destruct the microorganisms.106) Both xylitol and sorbitol are considered to 
interact with water molecule through hydrogen bonding and lower water activity, 
which may lead to hampering the hydrolytic ability of lysozyme.107) Furthermore, 
mucinous components in saliva could restrict the diffusion-controlled mobility of 
water molecules,108) which might result in inhibitory effects in salivary lysozyme 
significantly rather than HEWL. 
On the contrary, both xylitol and sorbitol have been suggested to make 
complex formation with polyvalent cations in the active site of peroxidase. The 
desolvation of the cations governs the thermodynamic properties to be favorable, 
which could increase the enzymatic activities of bLPO and salivary peroxidase.109) 
The enzymatic activity of GO-PO was not affected significantly by xylitol, but 
inhibited remarkably by sorbitol, though both xylitol and sorbitol enhanced the 
enzymatic activity of bLPO in this study. This means the critical point of catalytic 
activity should be GO rather than peroxidase. It would be possible that sugar 
alcohols affects the generation of H2O2 by regulating GO activity, as if 
methylglyoxal prevents the production of H2O2 by modifying the protein structure 
of GO through crosslinking.110) Furthermore, GO is known to lose 
thermodynamic stability when flavin adenine dinucleotide (FAD), a cofactor, is 
released. Some evidences that KCl, CaCl2, and xylitol were efficient at preventing 
from the release of FAD,111) might support the differential effects between xylitol 
and sorbitol. 
The effects of sugar alcohols on the enzymatic activities of lysozyme and 
peroxidase were significant in the solution phase, but not on the surface phase in 
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this study. Once sugar alcohols adsorbed onto the hydroxyapatite surfaces 
through hydrogen bonding, their structures would be reconstituted to surface-
oriented conformation and confined to the surface eventually.112,113) Therefore, it 
would be harder for sugar alcohols to interact with lysozyme or peroxidase and 
regulate enzymatic activities of them on the HA surfaces. 
The candidacidal activities of lysozyme, the peroxidase system, and the GO-
PO system were neither enhanced nor inhibited significantly by xylitol and 
sorbitol in the present study.  
Instead, C. albicans cultured in a variety of carbohydrate supplement media 
showed significant difference in the susceptibility to lysozyme. Xylitol as 
supplement media provided more susceptibility to lysozyme by the regulation of 
polysaccharides and proteins in yeast cell walls than other dietary 
carbohydrates.114) The epithelial adhesion of C. albicans grown in xylitol 
demonstrated significant decrease and marginal increase in sorbitol, while C. 
albicans grown in other dietary carbohydrates enhanced adhesion significantly.115) 
This means that the effect of sugar alcohol on candidacidal activities would not 
be associated with antimicrobial enzymes, but depend on other factors such as as 
adhesive capacity and cell wall components of fungus. 
The present study includes some limitations to extend the in vitro results into in 
vivo situations. There are more enzymes and other biological molecules, and more 
complicated interactions among them in human saliva than we have focused. The 
oral cavity is a dynamic open system composed of the different types of soft and 
hard tissues communicating with outer environment and inner gastrointestinal and 
respiratory systems, and it is different from a minimized closed system containing 
solution and synthetic HA surfaces. However, the results of the present study 
could help understand the molecular interactions in oral health care products and 
possibly in the oral cavity. 
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In conclusion, both xylitol and sorbitol inhibited the enzymatic activity of 
salivary lysozyme, while enhanced the enzymatic activity of bLPO and salivary 
peroxidase in solution. On the contrary, neither xylitol nor sorbitol has effect on 
the enzymatic activities of lysozyme and peroxidase on the HA surface. Sorbitol 
inhibited the enzymatic activity of GO-PO. The candidacidal activities of 
lysozyme, the peroxidase system, and the GO-PO system were not additive by 








Xylitol and sorbitol are the most widely used sugar alcohols as sweeteners 
and well known to anticariogenic property. Thus, they are often included in 
many commercialized oral health care products. It has been suggested that there 
must be concerted interactions between antimicrobial host proteins and sugar 
alcohols. Xylitol and sorbitol inhibited salivary lysozyme activity, but enhanced 
both bLPO and salivary peroxidase activities significantly in solution phase. 
Sorbitol, not xylitol, inhibited the enzymatic activity of GO-PO significantly. 
Both xylitol and sorbitol were not additive to the candidacidal activities of 
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Fig. 1. Influences of xylitol on the candidacidal activities of lysozyme, the 
peroxidase system, and the glucose oxidase-mediated peroxidase system. 
C, control (no antimicrobial, no xylitol); L, hen egg-white lysozyme (30 µg/mL); 
P, the peroxidase system (25 g/mL bLPO, 1 mM potassium thiocyanate, and 50 
M hydrogen peroxide); G, the glucose oxidase-mediated peroxidase system (25 
g/mL bLPO, 1 mM potassium thiocyanate, 10 units/mL GO, and 0.03 mg/mL 
glucose); X, xylitol (130 mM) 
Experiments were performed 8 times. 
 
 
Fig. 2. Influences of sorbitol on the candidacidal activities of lysozyme, the 
peroxidase system, and the glucose oxidase-mediated peroxidase system. 
C, control (no antimicrobial, no sorbitol); L, hen egg-white lysozyme (30 µg/mL); 
P, the peroxidase system (25 g/mL bLPO, 1 mM potassium thiocyanate, and 50 
M hydrogen peroxide); G, the glucose oxidase-mediated peroxidase system (25 
g/mL bLPO, 1 mM potassium thiocyanate, 10 units/mL GO, and 0.03 mg/mL 
glucose); S, sorbitol (130 mM) 































































Lysozyme activity (Units/mL) 
Sig. 
Sample only with Xylitol %Diff‡ Sample only with Sorbitol %Diff‡ 
HEWL (n=6) 130 1009.0  76.9 958.7  102.9 -5.15.1 0.080 130 920.0  29.2 918.7  66.6 -0.25.6 0.917 
Human saliva 
(n=8) 
32.5 450.5  290.6 427.8  279.3 -4.3  5.9b,c 0.021* 32.5 445.5  310.1 406.4  286.6 -8.7  4.5a,b,c 0.012* 
65§ 370.6  243.1 334.0  201.8 -8.2  4.6d,e 0.011* 65§ 425. 9  235.8 242.8  136.3 -39.4  21.6a 0.012* 
130 483.1  279.9 376.0  248.1 -25.1  9.1b,d 0.012* 130 441.9  282.4 337.5  254.0 -32.4  26.3b 0.012* 
260 393.3  221.9 299.6  195.2 -28.0  12.0c,e 0.012* 260 487.8  238.8 316.0  235.9 -40.9  21.8c 0.012* 
HEWL, hen egg-white lysozyme (30 μg/mL) 
Sig., Significance 
%Diff, percent changes of enzymatic activities in samples with sugar alcohol compared with samples without sugar alcohol 
The Wilcoxon signed rank test was used to analyze differences between the enzyme activities of samples with and without sugar alcohol.*P < 0.05 
The Kruskal-Wallis test was used to analyze differences of %Diff in human saliva according to the concentration of sugar alcohols. ‡P < 0.05 
The Mann-Whitney U-test with Bonferroni’s correction was used as post hoc analysis. Pair of the same alphabet denotes a significant difference. P < 0.0125 




Table 2. Influences of xylitol and sorbitol on the enzymatic activities of HEWL and whole salivary lysozyme on the surface phase 
 
Source of lysozyme Assay 
Xylitol 
(mM) 




Lysozyme activity (Units) 
Sig. 
Sample only with Xylitol Sample only with Sorbitol 
HEWL (n=6) 
I 130 4.7  0.4 4.7  0.7 0.752 130 4.5  0.6 4.4  0.6 0.753 
II 130 2.5  1.1 2.1  0.3 0.343 130 2.9  0.5 2.9  0.6 0.674 
Human Saliva (n=8) 
I 130 44.2  29.9 46.6  32.5 0.161 130 49.3  30.4 47.9  30.5 0.362 
II 130 15.8  7.9 14.2  8.0 0.327 130 20.3  15.7 21.8  15.1 0.161 
HEWL, hen egg-white lysozyme (30 μg/mL) 
Sig., Significance 
Assay I, Sugar alcohols were first adsorbed to hydroxyapatite beads and HEWL or human saliva was adsorbed next. 
Assay II, Sugar alcohols were pre-incubated with HEWL or human saliva, and the mixtures were adsorbed to hydroxyapatite beads. 



























Peroxidase activity (mUnits/mL) 
Sig. 
Sample only with Xylitol %Diff†,‡ Sample only with Sorbitol %Diff†,‡ 
bLPO 
(n=6) 
32.5 4.759  1.011 5.088  0.891 7.5  6.3b,c 0.046* 32.5 4.504  0.428 5.057  0.929 11.7  11.6c 0.075 
65 5.155  0.788 5.684  0.744 11.4  14.1 0.141 65 4.351  0.377 4.844  0.422 11.5  6.7e 0.028* 
130 5.355  0.916 6.980  1.073 31.4  16.5b 0.028* 130 4.844  0.424 5.782  0.595 19.8  13.4 0.027* 




32.5 1.376  0.298 1.522  0.349 10.6  6.0b,c 0.018* 32.5 1.862  0.815 2.018  0.824 10.2  10.7b,c 0.018* 
65 1.362  0.362 1.604  0.382 20.7  25.8 0.050 65 1.337  0.433 1.625  0.402 24.6 13.0e 0.012* 
130 1.438  0.467 2.004  0.664 39.0  13.4b 0.012* 130 1.369  0.429 1.942  0.678 42.0  22.0b 0.012* 
260 1.428  0.595 2.328  0.850 65.9  38.0c 0.012* 260 1.456  0.618 2.266  0.679 65.4  32.5c,e 0.012* 
bLPO, bovine lactoperoxidase  (25 μg/mL) 
Sig., Significance 
%Diff, percent changes of enzymatic activities in samples with sugar alcohol compared with samples without sugar alcohol 
The Wilcoxon signed rank test was used to analyze differences between the enzyme activities of samples with and without sugar alcohol. *P < 0.05 
The Kruskal-Wallis test was used to analyze differences of %Diff according to the concentration of sugar alcohols. †P < 0.05 in bLPO, ‡P < 0.05 in human saliva 
The Mann-Whitney U-test with Bonferroni’s correction was used as post hoc analysis. Pair of the same alphabet denotes a significant difference. P < 0.0125 









Table 4. Influence of the mixture of xylitol and sorbitol on the enzymatic activities of bLPO in the solution phase 
 
mM ratio of 
Xylitol : Sorbitol (n=8) 
Peroxidase activity (mUnits/mL) 
Sig. 
Sample only With mixture %Diff 
130 :0 5.355  0.916 6.980  1.073 31.4  16.5 0.028* 
97.5 : 32.5 5.356  0.337 6.828  0.780 27.3  8.8 0.028* 
65 : 65 5.727  0.474 7.114  0.538 24.8  12.1 0.028* 
32.5 : 97.5 5.782  0.869 7.266  1.085 25.7  4.5 0.027* 
0 : 130 4.844  0.424 5.782  0.595 19.8  13.4 0.027* 
bLPO, bovine lactoperoxidase  (25 μg/mL) 
Sig., Significance 
%Diff, percent changes of enzymatic activities in samples with sugar alcohol compared with samples without sugar alcohol 
The Wilcoxon signed rank test was used to analyze differences between the enzyme activities of samples with and without sugar alcohol. *P < 0.05 













Table 5. Influences of xylitol and sorbitol on the enzymatic activities of bLPO and whole salivary peroxidase on the surface phase 
 
Source of peroxidase Assay 
Xylitol 
(mg/mL) 




Peroxidase activity (mUnits) 
Sig. 
Sample only with Xylitol Sample only with Sorbitol 
bLPO (n=6) 
I 130 0.057  0.005 0.057  0.005 0.833 130 0.061  0.016 0.056  0.011 0.463 
II 130 0.054  0.007 0.058  0.004 0.345 130 0.062  0.011 0.065  0.007 0.416 
Human Saliva (n=8) 
I 130 0.021  0.009 0.021  0.007 0.865 130 0.030  0.009 0.028  0.006 0.528 
II 130 0.012  0.004 0.011  0.005 0.147 130 0.020  0.005 0.018  0.004 0.139 
bLPO, bovine lactoperoxidase  (25 μg/mL) 
Sig., Significance 
Assay I, Sugar alcohols were first adsorbed to hydroxyapatite beads and bLPO or human saliva was adsorbed next. 
Assay II, Sugar alcohols were pre-incubated with bLPO or human saliva, and the mixtures were adsorbed to hydroxyapatite beads. 














Table 6. Influence of the mixture of xylitol and sorbitol on the enzymatic activity of glucose oxidase-mediated peroxidase system 
 




GO-PO activity (OD) 
in glucose 0.02 mg/mL 
 GO-PO activity (OD) 
in glucose 0.04 mg/mL 
 GO-PO activity (OD) 




















































































































GO-PO, glucose oxidase-mediated peroxidase system 
%Diff, percent changes of enzymatic activities in samples with sugar alcohol compared with samples without sugar alcohol 
The Wilcoxon signed rank test was used to analyze differences between the enzyme activities of samples with and without sugar alcohol. *P < 0.05 
The Kruskal-Wallis test was used to analyze differences of %Diff according to the different ratios of sugar alcohols. †P < 0.05 
The Mann-Whitney U-test with Bonferroni’s correction was used as post hoc analysis. Pair of the same alphabet denotes a significant difference. P < 0.01 





Xylitol과 Sorbitol이 Lysozyme과 
Peroxidase에 관련된 효소활성 및 
Candidacidal 활성에 미치는 영향 
 
김 범 수 
서울대학교 대학원 치의학과 구강내과·진단학 전공 
(지도교수 고 홍 섭) 
 
Xylitol과 sorbitol은 감미제로 널리 사용되며 구강건강용품에 포함될 
경우 타액 내 여러 항균물질들과 반응할 것으로 추정된다. 이에 본 연구의 
목적은 xylitol과 sorbitol이 lysozyme, peroxidase 및 glucose 
oxidase-mediated peroxidase의 효소활성과 candidacidal 활성에 관
한 영향을 평가하기 위한 것이다. 
Xylitol과 sorbitol을 hen egg-white lysozyme, bovine 
lactoperoxidase, glucose oxidase-mediated peroxidase 및 비자극성 
전타액에 첨가하여 용액상태 및 hydroxyapatite 표면상태에서 효소활성
을 측정하였다. Lysozyme 효소활성은 Micrococcus lysodeikticus 현탁
액의 혼탁도 변화로 측정하였고, peroxidase 효소활성은 
hypothiocyanite에 의한 5,5’-dithiobis-2-nitrobenzoic acid의 산화
율 변화로 측정하였으며, glucose oxidase-mediated peroxidase 효소
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활성은 o-dianisidine 산화물 생성 정도로 측정하였다. Xylitol과 
sorbitol이 hen egg-white lysozyme, bovine lactoperoxidase, 
glucose oxidase-mediated peroxidase의 candidacidal 활성에 미치는 
영향은 Candida albicans ATCC 10231, 11006, 18804를 이용하고 군
집 형성 단위를 계수하여 측정하였다. 
Xylitol과 sorbitol은 용액상태와 hydroxyapatite 표면상태에서 hen 
egg-white lysozyme의 효소활성과 hydroxyapatite 표면상태에서 타
액 lysozyme의 효소활성에 영향을 미치지 않았으나, 용액상태에서 타액 
lysozyme의 효소활성을 저해하였다. Xylitol과 sorbitol은 용액상태에서 
bovine lactoperoxidase와 타액 peroxidase의 효소활성을 모두 증가시
켰으며, 이는 농도에 비례하였다. 하지만, 이러한 증가 현상은 
hydroxyapatite 표면상태에서는 관찰되지 않았다. Sorbitol은 glucose 
oxidase-mediated peroxidase의 효소활성을 유의하게 저해하였다. 
Xylitol과 sorbitol은 lysozyme, peroxidase 및 glucose oxidase-
mediated peroxidase의 candidacidal 활성에 영향을 미치지 않았다. 
결론적으로, xylitol과 sorbitol은 타액 lysozyme의 효소활성을 억제하
였고 bovine lactoperoxidase와 타액 peroxidase의 효소활성을 증가시
켰다. 이와 달리 lysozyme과 peroxidase의 candidacidal 활성에는 부가
적인 효과를 보이지 않았다. 
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